Europe — EMA
Osagrand (Sodium Ibandronate)
Sodium Ibandronate, the active ingredient in Osagrand, is a bis‑bisphosphonate presented as a oral tablet for skeletal health use. It helps manage conditions associated with increased bone resorption in post‑menopausal…
Request sourcing
What is Sodium Ibandronate?
Sodium Ibandronate, the active ingredient in Osagrand, is a bis‑bisphosphonate presented as a oral tablet for skeletal health use. It helps manage conditions associated with increased bone resorption in post‑menopausal women and men at risk of osteoporosis. GNH USA supplies Osagrand as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Osagrand as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Sodium Ibandronate used for?
Osagrand is a bis‑bisphosphonate that acts on bone metabolism to reduce skeletal loss.
- Osteoporosis: Reduces the risk of vertebral and hip fractures in post‑menopausal women and men with osteoporosis. - Paget's disease of bone: Controls abnormal bone remodeling and decreases bone pain. - Bone metastasis complications: Helps lower the incidence of skeletal‑related events in patients with bone metastases from solid tumours. - Hyper‑hormone -
